EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)

A Bleibtreu, M Bertine, C Bertin, N Houhou-Fidouh, B Visseaux

Médecine et Maladies Infectieuses · 2020-05 · 50 (3) · 243-251

DOI: 10.1016/j.medmal.2019.10.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Médecine et Maladies Infectieuses, 2020-05. Verfasst von A Bleibtreu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service des maladies infectieuses et tropicales, hôpitaux universitaires Pitié-Salpêtrière Charles Foix, AP-HP, Paris, France. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the first case of human infection by the Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia in June 2012, more than 2260 cases of confirmed MERS-CoV infection and 803 related deaths have been reported since the 16th of October 2018. The vast majority of these cases (71%) were reported in Saudi Arabia but the epidemic has now spread to 27 countries and has not ceased 6 years later, unlike SARS-CoV that disappeared a little less than 2 years after emerging. Due to the high fatality rate observed in MERS-CoV infected patients (36%), much effort has been put into understanding the origin and pathophysiology of this novel coronavirus to prevent it from becoming endemic in humans. This review focuses in particular on the origin, epidemiology and clinical manifestations of MERS-CoV, as well as the diagnosis and treatment of infected patients. The experience gained over recent years on how to manage the different risks related to this kind of epidemic will be key to being prepared for future outbreaks of communicable disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntiviral AgentsCamelusChiropteraCommunicable Diseases, EmergingCoronavirus InfectionsDisease ManagementDisease ReservoirsEpidemicsExtracorporeal Membrane OxygenationGenome, ViralGlobal HealthHumansHygieneMiddle East Respiratory Syndrome CoronavirusRisk FactorsSaudi ArabiaSurvival RateSymptom AssessmentTravel

Stichwörter der Autor:innen

CoronavirusEmerging diseaseMERS-CoVMaladies émergentesPneumoniaPneumonie

Substanzen

Antiviral AgentsViral Vaccines

Autor:innen und Institutionen

  • Service des maladies infectieuses et tropicales, hôpitaux universitaires Pitié-Salpêtrière Charles Foix, AP-HP, Paris, France.
  • Inserm, Laboratoire de Virologie, IAME, UMR 1137, Hôpital Bichat, Sorbonne Paris Cité, Université Paris Diderot, AP-HP, Paris, France.
  • Inserm, Laboratoire de Virologie, IAME, UMR 1137, Hôpital Bichat, Sorbonne Paris Cité, Université Paris Diderot, AP-HP, Paris, France. Electronic address: benoit.visseaux@aphp.fr.

Zitieren

APA

Bleibtreu, A., Bertine, M., Bertin, C., Houhou-Fidouh, N., & Visseaux, B. (2020). Focus on Middle East respiratory syndrome coronavirus (MERS-CoV). Médecine et Maladies Infectieuses, 50(3), 243-251. https://doi.org/10.1016/j.medmal.2019.10.004

Vancouver

Bleibtreu A, Bertine M, Bertin C, Houhou-Fidouh N, Visseaux B. Focus on Middle East respiratory syndrome coronavirus (MERS-CoV). Médecine et Maladies Infectieuses. 2020;50(3):243-251. doi:10.1016/j.medmal.2019.10.004

BibTeX
@article{Bleibtreu2020,
  author = {Bleibtreu, A and Bertine, M and Bertin, C and Houhou-Fidouh, N and Visseaux, B},
  title = {Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)},
  journal = {Médecine et Maladies Infectieuses},
  year = {2020},
  volume = {50},
  number = {3},
  pages = {243--251},
  doi = {10.1016/j.medmal.2019.10.004}
}
Kostenlos starten →